Cambridge Cognition Holdings Plc Is A Uk Based Neuroscience Technology Company Focused On Developing Digital Solutions For Assessing Cognitive Functionestablished In 2012 And Headquartered Near Cambridgethe Company Operates Internationallyincluding In Canadasouth Africaand The Usacambridge Cognition Is Listed On The London Stock Exchange The Company Offers A Variety Of Technologies And Services Designed To Support Central Nervous Systemcnsclinical Trialstheir Key Products Include The Cantab Digital Cognitive Assessment Platformwhich Aids In Drug Developmentand The Electronic Clinical Outcomes Assessmentecoatool For Managing Clinical Trial Dataother Offerings Include The Cognition Kit For Monitoring Brain Healthvoice Analysis Tools For Neurological Assessmentsan Econsent Solution For Patient Consent Processesand Clinpal For Managing Patient Workflowscambridge Cognition Serves Leading Pharmaceutical Organizations And Research Institutionsproviding Valuable Insights Across Various Therapeutic Areasincluding Adhdalzheimerae S Diseaseand Parkinsonae S Disease
